Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis.

Kunkl M, Sambucci M, Ruggieri S, Amormino C, Tortorella C, Gasperini C, Battistini L, Tuosto L.

Cells. 2019 Jun 11;8(6). pii: E575. doi: 10.3390/cells8060575.

2.

Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis.

Corsetti M, Ruocco G, Ruggieri S, Gasperini C, Battistini L, Volpe E.

Int J Mol Sci. 2019 Jun 8;20(11). pii: E2811. doi: 10.3390/ijms20112811.

3.

Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.

Capone A, Bianco M, Ruocco G, De Bardi M, Battistini L, Ruggieri S, Gasperini C, Centonze D, Sette C, Volpe E.

Cells. 2019 Jun 4;8(6). pii: E533. doi: 10.3390/cells8060533.

4.

Running-Activated Neural Stem Cells Enhance Subventricular Neurogenesis and Improve Olfactory Behavior in p21 Knockout Mice.

Nicolis di Robilant V, Scardigli R, Strimpakos G, Tirone F, Middei S, Scopa C, De Bardi M, Battistini L, Saraulli D, Farioli Vecchioli S.

Mol Neurobiol. 2019 May 6. doi: 10.1007/s12035-019-1590-6. [Epub ahead of print]

PMID:
31062248
5.

Efficacy of a Selective Binder of αVβ3 Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models.

Sartori A, Corno C, De Cesare M, Scanziani E, Minoli L, Battistini L, Zanardi F, Perego P.

Cancers (Basel). 2019 Apr 13;11(4). pii: E531. doi: 10.3390/cancers11040531.

6.

Integrin-targeted AmpRGD sunitinib liposomes as integrated antiangiogenic tools.

Bianchini F, De Santis A, Portioli E, Russo Krauss I, Battistini L, Curti C, Peppicelli S, Calorini L, D'Errico G, Zanardi F, Sartori A.

Nanomedicine. 2019 Jun;18:135-145. doi: 10.1016/j.nano.2019.02.015. Epub 2019 Mar 6.

PMID:
30849548
7.

Human primary macrophages scavenge AuNPs and eliminate it through exosomes. A natural shuttling for nanomaterials.

Logozzi M, Mizzoni D, Bocca B, Di Raimo R, Petrucci F, Caimi S, Alimonti A, Falchi M, Cappello F, Campanella C, Bavisotto CC, David S, Bucchieri F, Angelini DF, Battistini L, Fais S.

Eur J Pharm Biopharm. 2019 Apr;137:23-36. doi: 10.1016/j.ejpb.2019.02.014. Epub 2019 Feb 16.

PMID:
30779978
8.

Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma.

Bianchini F, Portioli E, Ferlenghi F, Vacondio F, Andreucci E, Biagioni A, Ruzzolini J, Peppicelli S, Lulli M, Calorini L, Battistini L, Zanardi F, Sartori A.

Cancer Lett. 2019 Apr 1;446:25-37. doi: 10.1016/j.canlet.2018.12.021. Epub 2019 Jan 11.

PMID:
30639534
9.

AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis.

Becher J, Simula L, Volpe E, Procaccini C, La Rocca C, D'Acunzo P, Cianfanelli V, Strappazzon F, Caruana I, Nazio F, Weber G, Gigantino V, Botti G, Ciccosanti F, Borsellino G, Campello S, Mandolesi G, De Bardi M, Fimia GM, D'Amelio M, Ruffini F, Furlan R, Centonze D, Martino G, Braghetta P, Chrisam M, Bonaldo P, Matarese G, Locatelli F, Battistini L, Cecconi F.

Dev Cell. 2018 Dec 3;47(5):592-607.e6. doi: 10.1016/j.devcel.2018.11.010.

PMID:
30513302
10.

Microenvironmental pH and Exosome Levels Interplay in Human Cancer Cell Lines of Different Histotypes.

Logozzi M, Mizzoni D, Angelini DF, Di Raimo R, Falchi M, Battistini L, Fais S.

Cancers (Basel). 2018 Oct 5;10(10). pii: E370. doi: 10.3390/cancers10100370.

11.

Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients.

Annibali V, Umeton R, Palermo A, Severa M, Etna MP, Giglio S, Romano S, Ferraldeschi M, Buscarinu MC, Vecchione A, Annese A, Policano C, Mechelli R, Pizzolato Umeton R, Fornasiero A, Angelini DF, Guerrera G, Battistini L, Coccia EM, Salvetti M, Ristori G.

J Neuroimmunol. 2018 Nov 15;324:165-171. doi: 10.1016/j.jneuroim.2018.09.005. Epub 2018 Sep 15.

PMID:
30270021
12.

The RNA binding protein Sam68 controls T helper 1 differentiation and anti-mycobacterial response through modulation of miR-29.

Volpe E, Cesari E, Mercatelli N, Cicconi R, De Bardi M, Capone A, Bonvissuto D, Fraziano M, Mattei M, Battistini L, Paronetto MP, Sette C.

Cell Death Differ. 2019 Jun;26(6):1169-1180. doi: 10.1038/s41418-018-0201-9. Epub 2018 Sep 26.

PMID:
30258098
13.

FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis.

Sambucci M, Gargano F, De Rosa V, De Bardi M, Picozza M, Placido R, Ruggieri S, Capone A, Gasperini C, Matarese G, Battistini L, Borsellino G.

Sci Rep. 2018 Feb 27;8(1):3674. doi: 10.1038/s41598-018-21861-5.

14.

Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.

Ottone T, Alfonso V, Iaccarino L, Hasan SK, Mancini M, Divona M, Lavorgna S, Cicconi L, Panetta P, Maurillo L, Del Principe MI, Irno Consalvo M, Franceschini L, Angelini DF, Battistini L, Guerrera G, De Bardi M, Fabiani E, Falconi G, Arcese W, Amadori S, Buccisano F, Venditti A, Voso MT, Lo-Coco F.

Am J Hematol. 2018 May;93(5):E120-E123. doi: 10.1002/ajh.25061. Epub 2018 Feb 24. No abstract available.

15.

Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis.

Amadio S, Parisi C, Piras E, Fabbrizio P, Apolloni S, Montilli C, Luchetti S, Ruggieri S, Gasperini C, Laghi-Pasini F, Battistini L, Volonté C.

Front Immunol. 2017 Nov 15;8:1529. doi: 10.3389/fimmu.2017.01529. eCollection 2017.

16.

Guidelines for the use of flow cytometry and cell sorting in immunological studies.

Cossarizza A, Chang HD, Radbruch A, Akdis M, Andrä I, Annunziato F, Bacher P, Barnaba V, Battistini L, Bauer WM, Baumgart S, Becher B, Beisker W, Berek C, Blanco A, Borsellino G, Boulais PE, Brinkman RR, Büscher M, Busch DH, Bushnell TP, Cao X, Cavani A, Chattopadhyay PK, Cheng Q, Chow S, Clerici M, Cooke A, Cosma A, Cosmi L, Cumano A, Dang VD, Davies D, De Biasi S, Del Zotto G, Della Bella S, Dellabona P, Deniz G, Dessing M, Diefenbach A, Di Santo J, Dieli F, Dolf A, Donnenberg VS, Dörner T, Ehrhardt GRA, Endl E, Engel P, Engelhardt B, Esser C, Everts B, Dreher A, Falk CS, Fehniger TA, Filby A, Fillatreau S, Follo M, Förster I, Foster J, Foulds GA, Frenette PS, Galbraith D, Garbi N, García-Godoy MD, Geginat J, Ghoreschi K, Gibellini L, Goettlinger C, Goodyear CS, Gori A, Grogan J, Gross M, Grützkau A, Grummitt D, Hahn J, Hammer Q, Hauser AE, Haviland DL, Hedley D, Herrera G, Herrmann M, Hiepe F, Holland T, Hombrink P, Houston JP, Hoyer BF, Huang B, Hunter CA, Iannone A, Jäck HM, Jávega B, Jonjic S, Juelke K, Jung S, Kaiser T, Kalina T, Keller B, Khan S, Kienhöfer D, Kroneis T, Kunkel D, Kurts C, Kvistborg P, Lannigan J, Lantz O, Larbi A, LeibundGut-Landmann S, Leipold MD, Levings MK, Litwin V, Liu Y, Lohoff M, Lombardi G, Lopez L, Lovett-Racke A, Lubberts E, Ludewig B, Lugli E, Maecker HT, Martrus G, Matarese G, Maueröder C, McGrath M, McInnes I, Mei HE, Melchers F, Melzer S, Mielenz D, Mills K, Mirrer D, Mjösberg J, Moore J, Moran B, Moretta A, Moretta L, Mosmann TR, Müller S, Müller W, Münz C, Multhoff G, Munoz LE, Murphy KM, Nakayama T, Nasi M, Neudörfl C, Nolan J, Nourshargh S, O'Connor JE, Ouyang W, Oxenius A, Palankar R, Panse I, Peterson P, Peth C, Petriz J, Philips D, Pickl W, Piconese S, Pinti M, Pockley AG, Podolska MJ, Pucillo C, Quataert SA, Radstake TRDJ, Rajwa B, Rebhahn JA, Recktenwald D, Remmerswaal EBM, Rezvani K, Rico LG, Robinson JP, Romagnani C, Rubartelli A, Ruckert B, Ruland J, Sakaguchi S, Sala-de-Oyanguren F, Samstag Y, Sanderson S, Sawitzki B, Scheffold A, Schiemann M, Schildberg F, Schimisky E, Schmid SA, Schmitt S, Schober K, Schüler T, Schulz AR, Schumacher T, Scotta C, Shankey TV, Shemer A, Simon AK, Spidlen J, Stall AM, Stark R, Stehle C, Stein M, Steinmetz T, Stockinger H, Takahama Y, Tarnok A, Tian Z, Toldi G, Tornack J, Traggiai E, Trotter J, Ulrich H, van der Braber M, van Lier RAW, Veldhoen M, Vento-Asturias S, Vieira P, Voehringer D, Volk HD, von Volkmann K, Waisman A, Walker R, Ward MD, Warnatz K, Warth S, Watson JV, Watzl C, Wegener L, Wiedemann A, Wienands J, Willimsky G, Wing J, Wurst P, Yu L, Yue A, Zhang Q, Zhao Y, Ziegler S, Zimmermann J.

Eur J Immunol. 2017 Oct;47(10):1584-1797. doi: 10.1002/eji.201646632. No abstract available.

17.

Programmed death 1 is highly expressed on CD8+ CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus.

Cencioni MT, Magliozzi R, Nicholas R, Ali R, Malik O, Reynolds R, Borsellino G, Battistini L, Muraro PA.

Immunology. 2017 Dec;152(4):660-676. doi: 10.1111/imm.12808. Epub 2017 Sep 21.

18.

Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients.

Logozzi M, Angelini DF, Iessi E, Mizzoni D, Di Raimo R, Federici C, Lugini L, Borsellino G, Gentilucci A, Pierella F, Marzio V, Sciarra A, Battistini L, Fais S.

Cancer Lett. 2017 Sep 10;403:318-329. doi: 10.1016/j.canlet.2017.06.036. Epub 2017 Jul 8.

PMID:
28694142
19.

High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro.

Noguera NI, Pelosi E, Angelini DF, Piredda ML, Guerrera G, Piras E, Battistini L, Massai L, Berardi A, Catalano G, Cicconi L, Castelli G, D'Angiò A, Pasquini L, Graziani G, Fioritoni G, Voso MT, Mastrangelo D, Testa U, Lo-Coco F.

Oncotarget. 2017 May 16;8(20):32550-32565. doi: 10.18632/oncotarget.15925.

20.

Acridine Orange/exosomes increase the delivery and the effectiveness of Acridine Orange in human melanoma cells: A new prototype for theranostics of tumors.

Iessi E, Logozzi M, Lugini L, Azzarito T, Federici C, Spugnini EP, Mizzoni D, Di Raimo R, Angelini DF, Battistini L, Cecchetti S, Fais S.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):648-657. doi: 10.1080/14756366.2017.1292263.

21.

Synthesis of Novel c(AmpRGD)-Sunitinib Dual Conjugates as Molecular Tools Targeting the αvβ3 Integrin/VEGFR2 Couple and Impairing Tumor-Associated Angiogenesis.

Sartori A, Portioli E, Battistini L, Calorini L, Pupi A, Vacondio F, Arosio D, Bianchini F, Zanardi F.

J Med Chem. 2017 Jan 12;60(1):248-262. doi: 10.1021/acs.jmedchem.6b01266. Epub 2016 Dec 20.

PMID:
27997164
22.

Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors.

Chiurchiù V, Leuti A, Cencioni MT, Albanese M, De Bardi M, Bisogno T, Centonze D, Battistini L, Maccarrone M.

Pharmacol Res. 2016 Nov;113(Pt A):313-319. doi: 10.1016/j.phrs.2016.09.003. Epub 2016 Sep 8.

PMID:
27616551
23.

Fas-Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis.

Volpe E, Sambucci M, Battistini L, Borsellino G.

Front Immunol. 2016 Sep 27;7:382. eCollection 2016. Review.

24.

Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.

Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F, Borsellino G, Battistini L, Schubart A, Mandolesi G, Centonze D.

J Neuroinflammation. 2016 Aug 26;13(1):207. doi: 10.1186/s12974-016-0686-4.

25.

Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.

Chiurchiù V, Leuti A, Dalli J, Jacobsson A, Battistini L, Maccarrone M, Serhan CN.

Sci Transl Med. 2016 Aug 24;8(353):353ra111. doi: 10.1126/scitranslmed.aaf7483.

26.

Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: A pilot study.

Buscarinu MC, Cerasoli B, Annibali V, Policano C, Lionetto L, Capi M, Mechelli R, Romano S, Fornasiero A, Mattei G, Piras E, Angelini DF, Battistini L, Simmaco M, Umeton R, Salvetti M, Ristori G.

Mult Scler. 2017 Mar;23(3):442-446. doi: 10.1177/1352458516652498. Epub 2016 Jul 11.

PMID:
27270497
27.

Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis.

Volpe E, Battistini L, Borsellino G.

Mediators Inflamm. 2015;2015:475158. doi: 10.1155/2015/475158. Epub 2015 Dec 7. Review.

28.

The p38 mitogen-activated protein kinase cascade modulates T helper type 17 differentiation and functionality in multiple sclerosis.

Di Mitri D, Sambucci M, Loiarro M, De Bardi M, Volpe E, Cencioni MT, Gasperini C, Centonze D, Sette C, Akbar AN, Borsellino G, Battistini L.

Immunology. 2015 Oct;146(2):251-63. doi: 10.1111/imm.12497. Epub 2015 Jul 6.

29.

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients.

Cencioni MT, Santini S, Ruocco G, Borsellino G, De Bardi M, Grasso MG, Ruggieri S, Gasperini C, Centonze D, Barilá D, Battistini L, Volpe E.

Cell Death Dis. 2015 Jun 11;6:e1785. doi: 10.1038/cddis.2015.164. No abstract available.

30.

A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia.

Angelini DF, Ottone T, Guerrera G, Lavorgna S, Cittadini M, Buccisano F, De Bardi M, Gargano F, Maurillo L, Divona M, Noguera NI, Consalvo MI, Borsellino G, Bernardi G, Amadori S, Venditti A, Battistini L, Lo-Coco F.

Clin Cancer Res. 2015 Sep 1;21(17):3977-85. doi: 10.1158/1078-0432.CCR-14-3186. Epub 2015 May 8.

31.

Organocatalytic, Asymmetric Eliminative [4+2] Cycloaddition of Allylidene Malononitriles with Enals: Rapid Entry to Cyclohexadiene-Embedding Linear and Angular Polycycles.

Brindani N, Rassu G, Dell'Amico L, Zambrano V, Pinna L, Curti C, Sartori A, Battistini L, Casiraghi G, Pelosi G, Greco D, Zanardi F.

Angew Chem Int Ed Engl. 2015 Jun 15;54(25):7386-90. doi: 10.1002/anie.201501894. Epub 2015 May 7.

PMID:
25950770
32.

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients.

Cencioni MT, Santini S, Ruocco G, Borsellino G, De Bardi M, Grasso MG, Ruggieri S, Gasperini C, Centonze D, Barilá D, Battistini L, Volpe E.

Cell Death Dis. 2015 May 7;6:e1741. doi: 10.1038/cddis.2015.100. Erratum in: Cell Death Dis. 2015;6:e1785.

33.

Epstein-Barr virus genetic variants are associated with multiple sclerosis.

Mechelli R, Manzari C, Policano C, Annese A, Picardi E, Umeton R, Fornasiero A, D'Erchia AM, Buscarinu MC, Agliardi C, Annibali V, Serafini B, Rosicarelli B, Romano S, Angelini DF, Ricigliano VA, Buttari F, Battistini L, Centonze D, Guerini FR, D'Alfonso S, Pesole G, Salvetti M, Ristori G.

Neurology. 2015 Mar 31;84(13):1362-8. doi: 10.1212/WNL.0000000000001420. Epub 2015 Mar 4.

34.

Pushing the boundaries of vinylogous reactivity: catalytic enantioselective mukaiyama aldol reactions of highly unsaturated 2-silyloxyindoles.

Curti C, Sartori A, Battistini L, Brindani N, Rassu G, Pelosi G, Lodola A, Mor M, Casiraghi G, Zanardi F.

Chemistry. 2015 Apr 20;21(17):6433-42. doi: 10.1002/chem.201500083. Epub 2015 Mar 3.

PMID:
25735832
35.

T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis.

Ruocco G, Rossi S, Motta C, Macchiarulo G, Barbieri F, De Bardi M, Borsellino G, Finardi A, Grasso MG, Ruggieri S, Gasperini C, Furlan R, Centonze D, Battistini L, Volpe E.

Clin Sci (Lond). 2015 Aug;129(4):291-303. doi: 10.1042/CS20140608.

PMID:
25700150
36.

Endocannabinoid signalling in innate and adaptive immunity.

Chiurchiù V, Battistini L, Maccarrone M.

Immunology. 2015 Mar;144(3):352-364. doi: 10.1111/imm.12441. Review.

37.

Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53.

Rossi S, Motta C, Studer V, Macchiarulo G, Volpe E, Barbieri F, Ruocco G, Buttari F, Finardi A, Mancino R, Weiss S, Battistini L, Martino G, Furlan R, Drulovic J, Centonze D.

Mol Neurodegener. 2014 Dec 12;9:56. doi: 10.1186/1750-1326-9-56.

38.

The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells.

Chiurchiù V, Lanuti M, De Bardi M, Battistini L, Maccarrone M.

Int Immunol. 2015 Mar;27(3):153-60. doi: 10.1093/intimm/dxu097. Epub 2014 Oct 25.

PMID:
25344934
39.

Exploring the vinylogous reactivity of cyclohexenylidene malononitriles: switchable regioselectivity in the organocatalytic asymmetric addition to enals giving highly enantioenriched carbabicyclic structures.

Dell'Amico L, Rassu G, Zambrano V, Sartori A, Curti C, Battistini L, Pelosi G, Casiraghi G, Zanardi F.

J Am Chem Soc. 2014 Aug 6;136(31):11107-14. doi: 10.1021/ja5054576. Epub 2014 Jul 24.

PMID:
25032901
40.

Enhancement of the uptake and cytotoxic activity of doxorubicin in cancer cells by novel cRGD-semipeptide-anchoring liposomes.

Battistini L, Burreddu P, Sartori A, Arosio D, Manzoni L, Paduano L, D'Errico G, Sala R, Reia L, Bonomini S, Rassu G, Zanardi F.

Mol Pharm. 2014 Jul 7;11(7):2280-93. doi: 10.1021/mp400718j. Epub 2014 May 22.

PMID:
24819754
41.

3-Alkenyl-2-silyloxyindoles in vinylogous Mannich reactions: synthesis of aminated indole-based scaffolds and products.

Ranieri B, Sartori A, Curti C, Battistini L, Rassu G, Pelosi G, Casiraghi G, Zanardi F.

Org Lett. 2014 Feb 7;16(3):932-5. doi: 10.1021/ol4036598. Epub 2014 Jan 16.

PMID:
24432768
42.

Synthesis, structure and inhibitory activity of a stereoisomer of oseltamivir carboxylate.

Sartori A, Dell'Amico L, Battistini L, Curti C, Rivara S, Pala D, Kerry PS, Pelosi G, Casiraghi G, Rassu G, Zanardi F.

Org Biomol Chem. 2014 Mar 14;12(10):1561-9. doi: 10.1039/c3ob42069h.

PMID:
24425043
43.

CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes.

Camperio C, Muscolini M, Volpe E, Di Mitri D, Mechelli R, Buscarinu MC, Ruggieri S, Piccolella E, Salvetti M, Gasperini C, Battistini L, Tuosto L.

Immunol Lett. 2014 Mar-Apr;158(1-2):134-42. doi: 10.1016/j.imlet.2013.12.020. Epub 2014 Jan 8.

PMID:
24412596
44.

Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells.

Loiarro M, Volpe E, Ruggiero V, Gallo G, Furlan R, Maiorino C, Battistini L, Sette C.

J Biol Chem. 2013 Oct 18;288(42):30210-22. doi: 10.1074/jbc.M113.490946. Epub 2013 Sep 9.

45.

Mononuclear phagocytes and marker modulation: when CD16 disappears, CD38 takes the stage.

Picozza M, Battistini L, Borsellino G.

Blood. 2013 Jul 18;122(3):456-7. doi: 10.1182/blood-2013-05-500058. No abstract available.

46.

Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.

Abrahamsson SV, Angelini DF, Dubinsky AN, Morel E, Oh U, Jones JL, Carassiti D, Reynolds R, Salvetti M, Calabresi PA, Coles AJ, Battistini L, Martin R, Burt RK, Muraro PA.

Brain. 2013 Sep;136(Pt 9):2888-903. doi: 10.1093/brain/awt182. Epub 2013 Jul 17.

47.

Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.

Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, Mechelli R, Salvetti M, Borsellino G, Aloisi F, Battistini L.

PLoS Pathog. 2013;9(4):e1003220. doi: 10.1371/journal.ppat.1003220. Epub 2013 Apr 11.

48.

Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice.

Mozzetta C, Consalvi S, Saccone V, Tierney M, Diamantini A, Mitchell KJ, Marazzi G, Borsellino G, Battistini L, Sassoon D, Sacco A, Puri PL.

EMBO Mol Med. 2013 Apr;5(4):626-39. doi: 10.1002/emmm.201202096. Epub 2013 Mar 18.

49.

Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.

Chiurchiù V, Cencioni MT, Bisicchia E, De Bardi M, Gasperini C, Borsellino G, Centonze D, Battistini L, Maccarrone M.

Ann Neurol. 2013 May;73(5):626-36. doi: 10.1002/ana.23875. Epub 2013 Apr 17.

PMID:
23447381
50.

Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two.

Bisicchia E, Chiurchiù V, Viscomi MT, Latini L, Fezza F, Battistini L, Maccarrone M, Molinari M.

Cell Mol Life Sci. 2013 Jun;70(12):2191-204. doi: 10.1007/s00018-012-1253-5. Epub 2013 Jan 8.

PMID:
23296125

Supplemental Content

Loading ...
Support Center